#biopharmaceuticals

[ follow ]
#insider-buying #pfizer #dividend-yield #long-term-growth #investment-risks #ipo #maplight-therapeutics
Venture
from24/7 Wall St.
2 days ago

This 6.5%Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven't Priced In

Pfizer offers a 6.5% dividend yield and potential for long-term growth despite facing challenges and uncertainties in the biopharmaceutical market.
#insider-buying
more#insider-buying
fromLondon Business News | Londonlovesbusiness.com
8 months ago

Reeves hit with another blow as AstraZeneca considering leaving the UK

Sir Pascal Soriot has repeatedly highlighted the need for Europe to enhance its incentives for new medicines, warning that jobs could relocate to the US if these conditions remain unchanged.
UK news
from24/7 Wall St.
9 months ago

This Once Dominant Dividend Stock May Be About to Come Back to Life in July

Bristol-Myers Squibb, down over 42% from its peak, is becoming an attractive buy due to its high dividend yield and potential for turnaround.
Startup companies
Digital life
fromComputerWeekly.com
11 months ago

Interview: Markus Schummelfeder, CIO, Boehringer Ingelheim | Computer Weekly

Markus Schümmelfeder's vision as CIO has transformed Boehringer Ingelheim into a data-enabled organisation, emphasizing technology's role in business processes.
[ Load more ]